- $5.85bn
- $6.10bn
- $881.66m
- 97
- 13
- 79
- 67
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 626 | 591 | 707 | 861 | 882 |
Cost of Revenue | |||||
Gross Profit | 262 | 245 | 300 | 378 | 400 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 571 | 535 | 643 | 758 | 771 |
Operating Profit | 55.3 | 55.9 | 64.1 | 103 | 110 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 45.8 | 48.4 | 56.2 | 87.2 | 83.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 40.8 | 44.5 | 50.3 | 74.1 | 72.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 40.8 | 44.5 | 50.3 | 74.1 | 72.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 40.8 | 44.5 | 50.3 | 74.1 | 72.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.56 | 1.35 | 1.86 | 2.17 | 2.39 |